Skip to content

To study the Safety and Efficacy of Investigational Hair oil in comparison with coconut oil and comparator Hair oil in subjects with mild to severe Hair fall

A Prospective study to evaluate the Safety and Efficacy of Investigational Hair oil in comparison with coconut oil and comparator Hair oil in subjects with mild to severe Hair fall

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024824
Enrollment
40
Registered
2020-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L63- Alopecia areata

Interventions

Intervention1: Pramika Hair Oil: Pramika Hair oil (A Siddha Proprietary Formulation) Study duration - 6 weeks Control Intervention1: Coconut Oil: Coconut oil Study duration - 6 weeks Control Intervent

Sponsors

Thai Herbals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Willingness to give written informed consent 2.Subjects with mild to severe hair fall. (Severe -50 percent, moderate-30 percent,mild- 20 percent) 3.Subjects with no skin allergies to any cosmetic products 4.Willingness to discontinue any hair care product other than the IP throughout the study. 5.Subjects who is not willing to color their hair throughout the treatment period 6.Subjects willing to discontinue all the hair care treatments such as hair spa,straightening, curling, hair perming, etc. throughout the treatment period 7.Willingness to follow the protocol requirements as evidenced by written informed consent 8.Comprehension of the nature and purpose of the study and compliance with the requirement of the entire procedure 9.In addition, female subjects selected for the study must be able to use a medically acceptable form of birth control during the study or be surgically sterile or be post menopausal for at least 1 year

Exclusion criteria

Exclusion criteria: 1.Subjects with known hypersensitivity to any specific ingredients of IPâ??s 2.Subjects below the age of 18 years and subjects above 50 years 3.Subjects not willing to participate in the study 4.Subjects who have previously undergone hair transplantation procedures 5.Subjects with other skin diseases. 6.Subjects are being treated for hair fall or severe active infection of any type. 7.Presence of any underlying significant uncontrolled medical illness involving the cardiovascular, respiratory, renal, gastrointestinal, hepatic,immunologic, hematological, endocrine, or nervous systems or psychiatric disease, HIV. 8.Subjects with pre-existing scalp disorder such as scalp psoriasis, lichen planus, lichen planopilaris, DLE-Discoid lupus erythematosus, sebopsoriasis will be excluded from the study. 9.A female subject who is breast-feeding, pregnant or intends to become pregnant during the study. 10.Participating in a clinical research trial within 30 days prior to screening. 11.Subjects who are cognitively impaired and/or who are unable to give informed consent 12.Any other health or mental condition that in the Investigatorâ??s opinion may adversely affect the ability to complete the study or its measures or that may pose significant risk to the subject.

Design outcomes

Primary

MeasureTime frame
1.Hair fall Reduction 2.Hair growth stimulation 3.Growth of existing hair 4.New hair growth 5.Hair damage protection 6.Shine and health of hair 7.Cooling effect 8.Dandruff control Timepoint: Visit1 day1 Visit2 day7 Viist3 day10 Visit4 day15 Visit5 day21 Visit6 day28 Visit7 day42

Secondary

MeasureTime frame
1.Visible hair fall reduction 2.Hair growth improvement -length and thickness 3.Reduction of hair damage -split ends and breakages 4.Improvements in hair strength and elasticity of hair 5. Texture and appearance softness, smoothness and shine 6.Scalp itching and dandruff 7.Product lightness and non-stickiness 8.Feedback on product smell and smell retention on hair Timepoint: Visit7 day 42

Countries

India

Contacts

Public ContactKeerthica C

I5 Clinical Research Pvt Ltd

yogesh@iddresearch.com9717832255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026